Clinical presentation and outcome of Tuberculosis in Human Immunodeficiency Virus infected children on anti-retroviral therapy
<p>Abstract</p> <p>Background</p> <p>The tuberculosis (TB) and human immunodeficiency virus (HIV) epidemics are poorly controlled in sub-Saharan Africa, where highly active antiretroviral treatment (HAART) has become more freely available. Little is known about the clin...
Main Authors: | Walters Lourens O, Schaaf H Simon, Rabie Helena, Cotton Mark F, Walters Elisabetta, Marais Ben J |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2008-01-01
|
Series: | BMC Pediatrics |
Online Access: | http://www.biomedcentral.com/1471-2431/8/1 |
Similar Items
-
Determination of Lipid Derangements in Human Immunodeficiency Virus Patients Undergoing Anti-Retroviral Therapy
by: Qamar Bashir, et al.
Published: (2022-12-01) -
Stigma toward people living with Human Immunodeficiency Virus: Insights from Anti-Retroviral Therapy clients in north-eastern Ghana
by: Jemina Lamisi Y. Ayiigah, et al.
Published: (2024-01-01) -
Perinatal tuberculosis—An approach to an under-recognized diagnosis
by: H. Simon Schaaf, et al.
Published: (2023-11-01) -
Complementary surveillance strategies are needed to better characterise the epidemiology, care pathways and treatment outcomes of tuberculosis in children
by: Karen du Preez, et al.
Published: (2018-03-01) -
Predictors of human immunodeficiency virus and tuberculosis co-infection
by: Venkataramana Kandi
Published: (2015-02-01)